Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|169|2|228-240

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.2, 2015-04, pp. : 228-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 550-558

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 4, 2013-04 ,pp. : 324-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Augmenting Clinical Interpretability of Thiopurine Methyltransferase Laboratory Evaluation

By  

Oncology, Vol. 86, Iss. 3, 2014-03 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

Intraocular relapse of childhood acute lymphoblastic leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 121, Iss. 2, 2003-04 ,pp. : 280-286

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated Serum Pancreatic Enzyme Activities in Kidney Transplant Recipients and Azathioprine Drug Therapy: Is Thiopurine Methyltransferase Polymorphism One Missing Link?

By  

Urologia Internationalis, Vol. 68, Iss. 2, 2002-02 ,pp. : 135-136

Karger

Access to resources Recommend Favorite